
* Lindt & Spruengli appointed Andreas Pfluger as a member of top management effective immediately, and Thomas Linemayr is promoted to extended group management, aimed at equipping the chocolate maker to the ongoing geographic expansion. * Barry Callebaut said a dispute with Singapore’s Petra Foods Ltd over the purchase of a cocoa business will affect the calculation of the final purchase consideration and goodwill, though it doesn’t affect the operational performance or the integration of the recently acquired business. * GAM said third-quarter assets under management stood at 72.1 billion Swiss francs ($79.96 billion), with modest net new money inflows and strong positive market performance largely offset by unfavorable foreign exchange movements.


* Roche’s unit Genentech said it had gained FDA approval for a new subcutaneous formulation of Actemra for use in adult patients living with moderately to severely active rheumatoid arthritis.
